1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine
Chemical compound
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine, also known as 3C-PEP, is a chemical compound that belongs to the class of piperazine derivatives. It is structurally related to other phenylpiperazine compounds and has been studied for its potential pharmacological effects.
Chemical Structure[edit]

The chemical structure of 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine consists of a piperazine ring substituted with a 3-chlorophenyl group and a 2-phenylethyl group. The presence of the chlorine atom on the phenyl ring is a distinguishing feature of this compound.
Synthesis[edit]
The synthesis of 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine typically involves the reaction of 1-(3-chlorophenyl)piperazine with a suitable phenylethyl halide under basic conditions. This reaction results in the formation of the desired compound through nucleophilic substitution.
Pharmacology[edit]
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine has been investigated for its potential effects on the central nervous system. Like other piperazine derivatives, it may interact with various neurotransmitter systems, although specific receptor targets and mechanisms of action are not well-defined.
Potential Uses[edit]
While 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine has been studied in a research context, it is not approved for medical use. Its potential applications remain largely theoretical and require further investigation to determine any therapeutic benefits or risks.
Safety and Toxicology[edit]
The safety profile of 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine is not well-established. As with many research chemicals, caution is advised due to the lack of comprehensive toxicological data.
Related pages[edit]
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian